,i #aaeth ,,congress #ast ,session ,h4 ,r4 #cchb ,,in ,,the ,,house ,,of ,,representatives ,july #be1 #bjag,ms4 ,clark of ,massachusetts 7for herself and ,mr4 ,bucshon7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,public ,health ,service ,act to better address substance use and substance use disorders among young people4 #a4 ,short title ,this ,act may be cited as the ,youth ,opioid ,use ,treatment ,help ,act of #bjag or the ,,youth ,act4 #b4 ,reauthorization of substance abuse treatment services for children1 adolescents1 and young adults ,section #ead of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;bb-#g7 is amended-- 7#a7 in the section heading1 by striking children and adolescents and inserting children1 adolescents1 and young adults2 7#b7 in subsection 7a77#b71 by striking children1 including and inserting children1 adolescents1 and young adults1 including2 and 7#c7 by striking children and adolescents each place it appears and inserting children1 adolescents1 and young adults4 #c4 ,access to medication-assisted treatment for adolescents and young adults demonstration program 7a7 ,in general ,the ,secretary of ,health and ,human ,services1 acting through the ,director of the ,agency for ,healthcare ,research and ,quality 7in this section referred to as the ,director71 shall award grants to eligible entities to establish demonstration programs to-- 7#a7 expand access to medication-assisted treatment for opioid use disorders among adolescents and young adults2 7#b7 identify and test solutions for overcoming barriers to implementation of medication-assisted treatment for adolescents and young adults2 or 7#c7 create and distribute resources on medication-assisted treatment training and implementation for providers of health care to children1 adolescents1 and young adults4 7b7 ,eligible entities ,to be eligible to receive a grant under subsection 7a71 an entity shall-- 7#a7 be a ,state1 political subdivision of a ,state1 ,indian tribe1 or tribal organization1 professional family medicine provider organization1 professional pediatric provider organization or other organization representing providers of health care to children1 adolescents1 and young adults1 professional addiction medicine provider organization1 hospital1 an institution of higher education1 or other appropriate public or nonprofit institution2 and 7#b7 certify that it is in compliance with all applicable registration and licensing requirements4 7c7 ,application ,to seek a grant under this section1 an entity shall submit to the ,director an application at such time1 in such manner1 and containing such information as the ,director may require4 7d7 ,duration ,an eligible entity may receive funds under this section to carry out a demonstration program described in this section for a period of not greater than #c years4 ,after the first year for which funding is provided to an eligible entity for a demonstration program1 funding may be provided under this section for a subsequent year for such program only upon review of such program by the ,director and approval by the ,director of such subsequent year of funding4 7e7 ,reports 7#a7 ,by grant recipients ,each eligible entity awarded a grant under this section for a demonstration program shall submit to the ,director progress reports on such demonstration program at such times1 in such manner1 and containing such information as the ,director may require4 7#b7 ,by ,director ,not later than one year after the date on which all demonstration programs funded under this section have been completed1 the ,director shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate1 and the ,committee on ,energy and ,commerce of the ,house of ,representatives a report that-- 7,a7 describes the availability of medication-assisted treatment for adolescents and young adults with opioid use disorders in the ,united ,states1 including barriers to such treatment2 7,b7 describes the specific demonstration programs carried out pursuant to this section2 7,c7 evaluates the effectiveness of such programs2 7,d7 evaluates any unintended consequences of such programs2 and 7,e7 provides recommendations for ensuring that medication-assisted treatment is accessible to adolescents and young adults with opioid use disorders4 7f7 ,definitions ,in this section3 7#a7 ,the phrase adolescents and young adults means individuals who have attained #aj years of age and not yet attained #bf years of age4 7#b7 ,the term medication-assisted treatment means the combination of pharmacological treatments approved by the ,food and ,drug ,administration1 and counseling and behavioral therapies1 for the treatment of substance use disorders4 7#c7 ,the term opioid use disorder means a problematic pattern of opioid use leading to clinically significant impairment or distress occurring within a #ab-month period4 7#d7 ,the term pediatric health care provider means a provider of health care to individuals who have attained #aj years of age and not yet attained #bf years of age4 7#e7 ,the term professional family medicine provider organization means a national organization whose members consist primarily of family medicine providers4 7#f7 ,the term professional pediatric provider organization means a national organization whose members consist primarily of pediatric health care providers4 7g7 ,authorization of appropriations ,there is authorized to be appropriated #e1jjj1jjj to carry out this section4